Back To Search Results

Enteric Feedings

Editor: Menogh Valentine Updated: 12/26/2022 10:36:41 AM

Introduction

Enteral nutrition uses the gastrointestinal tract to supply nutrients. This can be accomplished by feeding by mouth or through a feeding tube. Advantages of enteral nutrition over parenteral nutrition include safety, effectiveness, decreased risk of infection, decreased cost, prevention of gut atrophy, and preservation of the gut's barrier function. 

Artificial nutrition refers to providing or supplementing daily metabolic nutrition requirements in patients with contraindications to feeding through the mouth or those with inadequate oral intake. Artificial nutrition is provided through parental or enteral access. Parenteral nutrition is provided through a large vein in the central venous system. Enteral nutrition uses the gastrointestinal (GI) tract to provide nutrition. Enteral access can be obtained by passing a feeding tube through the nose (nasogastric and nasojejunal) and mouth (orogastric) at the bedside. It can also be achieved by surgically implanting a feeding tube into the gut, such as a feeding gastrostomy (stomach) or a feeding jejunostomy (jejunum). Historically, enteral nutrition has not been as well emphasized as parenteral nutrition because of the belief that many disease states prevent the gut from normal absorptive function. However, enteral nutrition is well tolerated even in severe disease states in critically ill patients. Moreover, enteral nutrition has been associated with reduced infectious complications, lower costs, and reduced length of hospital stay.[1]

Indications

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Indications

Indications for Enteral Feeding

Enteral tube feeding is indicated in patients who cannot maintain adequate oral intake of food or nutrition to meet their metabolic demands. Healthcare professionals commonly use enteral feeding in patients with dysphagia. Patients with dysphagia sometimes cannot meet their daily nutritional needs, even with modification of food texture or consistency.

For enteral feeding to be successful, the GI tract should be accessible and functional. Inaccessible GI tracts, malabsorption, and severe GI losses might challenge enteral feeding. The alternative is parenteral feeding.

Indications

  • Comatose patients on mechanical ventilation or with a severe head injury
  • A neuromuscular disorder affecting swallowing reflex: Parkinson's disease, multiple sclerosis, cerebrovascular accident.
  • Severe anorexia from chemotherapy, HIV, sepsis
  • Upper GI obstruction esophageal stricture or tumor
  • Conditions associated with increased metabolic and nutritional demands include sepsis, cystic fibrosis, and burns [2]
  • Mental illness like dementia [3][4][5][6][7][8]

Enteral Nutrition in Critical Illness

There is overwhelming evidence that enteral feeding is the best approach for nutrition in critically ill patients. The GRADE system working group came up with the following recommendation.

  • Enteral nutrition has been associated with an improvement in nutrition variables, a reduction in the length of hospital stay, and a lower incidence of infection.
  • Critically ill patients who cannot tolerate oral feeding for greater than 72 hours should receive specialized nutritional support.
  • Enteral nutrition is the preferred mode of feeding when compared to parenteral nutrition.
  • Enteral nutrition should be started within 48 hours of admission.
  • It should provide between 25 to 30 kcal/kg per day.
  • The goal caloric intake should be achieved within 48 to 72 hours.
  • Enteral nutrition should be deferred until the patient is stable hemodynamically.
  • The presence of flatus, stool passage, or bowel sounds should not be a prerequisite for starting enteral nutrition.[8]

Caloric Consideration

Resting energy expenditure can be calculated using indirect calorimetry. This method calculates the caloric requirements in patients requiring enteral feeding. When indirect calorimetry is unavailable, approximately 25 kcal/kg per day is the approximate energy requirement. Clinicians can calculate caloric intake for patients on mechanical ventilation using the Penn State equation.[9]

Carbohydrate intake should be approximately 4 gm/kg daily with a target glucose level below 180 mg/dl. Lipid intake should be between 0.7 to 1.5 gm/kg per day. Amino acid should be adjusted to 1 to 1.8 g/kg per day with an adequate supply of micronutrients.[10]

It is highly recommended that enteral feeding be started as early as possible in critically ill patients.[10][11][12]

Hypocaloric enteral intake is beneficial at the initial stage of critical illness as it can help prevent hyperglycemia, which is linked to a higher risk of mortality. Some authorities recommend around 80% of nutritional needs in the first 7 to 8 days of illness, which can gradually increase during recovery.

Contraindications

Absolute Contraindications

  • Hemodynamic instability with poor end-organ perfusion. Enteral feeding in patients with bowel ischemia or necrosis can make a bad situation worse
  • Active GI bleeding
  • Small or large bowel obstruction
  • Paralytic ileus secondary to electrolyte abnormalities, peritonitis

 Relative Contraindications

  • Moderate to severe malabsorption
  • Diverticular disease
  • Fistula in the small bowel
  • Short bowel disease in the early stages.

Special Cases

Acute Kidney Injury

In acute kidney injury (AKI), nutritional support conserves lean body mass and energy reserve and prevents malnutrition.

Patients with AKI and renal failure might be in a non-hypercatabolic or hypercatabolic state with excessive sodium, potassium, and phosphate load. In a non-hypercatabolic state, high-energy enteral nutrition with normal protein content and low sodium, potassium, and phosphate load are recommended.[13][14] In AKI with a hypercatabolic phase, a low protein (2 to 2.5g/kg per day) and low electrolyte enteral nutrition are recommended. Besides monitoring electrolytes like sodium, potassium, phosphorus, and calcium, clinicians should pay special attention to micronutrients like zinc, selenium, thiamin, folic acid, and vitamins A, C, and D.

Acute Liver Failure and Liver Transplantation

Liver failure is associated with the loss of the synthetic function of the liver. Liver failure patients also have an impaired ability to synthesize clotting factors. Enteral feeding should be cautiously approached in patients with liver failure because of the inherent risk of gastrointestinal bleeding from varices and coagulopathy. In acute liver failure, parenteral nutrition might be better if the gut is not viable or if the risk of hepatic encephalopathy is high. A balanced energy supply from carbohydrates and protein is recommended if enteral feeding is used. Caloric intake should be around 25 kcal/kg per day. Enteral feeds should contain adequate potassium, magnesium, and zinc. In liver transplant patients, early enteral feeding via a transpyloric approach is recommended.[15]

Acute Lung Injury (ALI), Acute Respiratory Distress Syndrome (ARDS)

This is 1 of the most common reasons for admission into the intensive care unit (ICU). Daily protein intake should be around 1 to 1.8 g/kg daily. The use of high-fat and low carbohydrate is not indicated. ALI and ARDS require an enteral diet rich in omega-3 fatty acids and antioxidants.[16]

Multiple Trauma

A patient who sustained multiple trauma should be started early enteral feeding. We recommend that trauma patients be started on a total caloric intake of about 25 to 30 kcal/kg daily. We also recommend arginine and omega in patients with multiple traumas.[17][18][19]

Abdominal Surgery

The nutritional needs of patients with abdominal surgery are similar to those of other critically ill patients. Surgery causes both inflammatory and metabolic changes in the body. A post-surgical patient with malnutrition might have delayed wound healing and dehiscence and decreased immunological functions, placing the patient at risk for infectious and cardiopulmonary complications. This can prolong hospital stays and cause a higher rate of mortality.[20]

Acute Pancreatitis

Inflammation of the pancreas can provoke a systemic inflammatory response syndrome. This causes a hypermetabolic, hyperdynamic, and catabolic state. Classically, acute pancreatitis is treated with bowel rest and parenteral nutrition. It has been shown that this approach is associated with high morbidity and mortality. In acute pancreatitis, there is intestinal barrier dysfunction, which is associated with multiple organ failure, pancreatic necrosis, and mortality. Based on these facts, the current recommendation is to start early enteral feeding via the jejunum within 48 hours of hospitalization.[21][22]

Equipment

Types of Enteral Feeding Tubes

There are several types of enteral feeding tubes. They are usually made of polyurethane or silicone. Feeding tube diameters are measured in French units (Fr). Each French unit is equivalent to 0.33 millimeters. Feeding tubes are usually denoted or classified by the site of placement.

  • Nasogastric tube
  • Nasoduodenal tube
  • Nasojejunal tube
  • Gastrostomy tube
  • Jejunostomy tube
  • Gastrojejunal tube

Tubes can be placed:

  • Manually
  • Endoscopically 
  • Surgically
  • By interventional radiology[23]

Nasogastric Tube

A nasogastric tube (NG) is mainly utilized for patients with no issues with vomiting, gastroesophageal reflux (GER), poor gastric emptying, and no evidence of ileus or small or large bowel obstruction. NG tube is risky in patients with poor swallowing coordination or reflex. Fine bore 5 to 8 Fr NG is usually recommended. If there is a need for nasogastric decompression, a larger bore NG can be used. For patient safety, the recommendation is that well-trained and qualified medical personnel place the feeding tube. After the placement, the position should be verified by auscultation or x-ray. Although not routinely recommended, an x-ray confirms NG tube placement for high-risk patient populations, specifically intensive care and neonatal patients. The National Patient Safety Agency advocates analyzing gastric aspirate with pH-graded paper to confirm the proper position. The pH should be less than 5.5 before feeding is started.

Nasoduodenal and Nasojejunal Tube

These are enteral feeding tubes with a tip in the duodenum or jejunum. They can be placed at the bedside or with fluoroscopy guidance.

Gastrostomy Tube

The feeding tube passes through the anterior abdominal wall into the gastric cavity. A gastrostomy tube is utilized for patients who require long-term feeding. It can be placed via endoscopy percutaneous endoscopic gastrostomy (PEG).[24][25] PEG tubes are for patients who require long-term nutritional support. PEG tube with jejunal extension is associated with tube dislocation and dysfunction.[25] A gastrostomy feeding tube can also be placed radiologically, surgically, or via endoscopy.[26]

Jejunostomy Tube

This feeding tube passes through the anterior abdominal wall into the jejunum. It can be placed surgically or radiologically by extending through the pylorus into the jejunum. Endoscopically, a percutaneous endoscopic gastrojejunostomy (PEGJ) can be performed. Direct percutaneous endoscopic jejunostomy tube placement is less commonly performed, but PEGJs are more robust and less likely to be dislocated.[25]

Personnel

Nutritional Support Team

Using the current protocol and guidelines, an interprofessional approach is the best way to manage patients who require enteral feeding. A nutrition support team comprises the physician, nurse, clinical pharmacist, and nutritionist.[27] Provision of optimal enteral nutrition can be achieved by:

  • Identification of patients at risk for malnutrition
  • Performance of a comprehensive assessment of the patient's nutritional status
  • Provision of a safe, adequate, and effective nutritional support

 Services that the nutrition support team can offer include:

  • Consultation service for nutritional support
  • Development of nutrition protocol for both medical and nursing staff
  • Research and quality improvement projects in nutrition
  • Staff education and development

Technique or Treatment

Delivery Techniques

There are several modalities of delivering enteral feeds. Traditionally, enteral feeding should be started about 12 to 24 hours after the placement of PEG. This allows for a better seal to develop at the site of insertion of the PEG tube.[27][28] More recent studies have shown that enteral feeding can be initiated from 3 to 4 hours after the insertion of the PEG.

Bolus Intermittent Feeding with a Bulb or Syringe

Enteral feeding delivers about 100 to 400 ml over 5 to 10 minutes. It is mostly used in ambulatory settings, and the risk of aspiration is high.

Cyclic Intermittent Feeding

This method is used for patients in a semi-recumbent position. Enteral feeding is delivered via a pump or gravity and lasts 8- 16 hours.

Intermittent Drip

This is popular for home enteral feeding. Approximately 1.5 to 2 liters of feeding can be delivered overnight over an 8 to 16-hour period. Feeding is delivered via gravity or pump.

Constant Infusion

This method is used for bedridden patients. Feeding is usually delivered via gravity or pump. The head is inclined at 45% to reduce aspiration or regurgitation.

There are 4 techniques for jejunostomy placement: open surgical technique (longitudinal or transverse Witzel), laparoscopic technique, needle catheter technique, and percutaneous technique. Although the preferred technique depends on the type of patient and the surgeon's expertise, minimally invasive techniques are the standard of care.

Open Surgical Technique

The patient is prepped and draped with sterility. An exit site is chosen in the LUQ, preferably a few centimeters away from the midline. A stab incision is made and dissected with tonsil forceps. A loop of proximal jejunum is delivered into the wound. A diamond-shaped purse-string suture is tied to the antimesenteric border of the jejunal loop, and a small incision is given in the center of the suture, large enough to accommodate the jejunostomy tube. The tube is inserted into the jejunum with care to ensure enough tube length to prevent the backflow of tube feeds. The purse-string suture is secured tightly without kinking the tube.

The Witzel technique is used to prevent extravasation of enteric contents at the exit site of the jejunostomy tube. This involves placing the tube along the length of the bowel for about 5 cm proximally and creating a serosal tunnel to imbricate the tube into position. The serosal tunnel is created by taking perpendicular Lambert sutures with 3-0 silk on either side of the tube. Once the tube is delivered through the abdominal wall, the jejunal loop with seromuscular sutures is attached to the abdominal wall. This is done to prevent bowel obstruction or volvulus.[10]

Laparoscopic Technique 

It is a minimally invasive approach and is the preferred modality with the current advancement of technology. The patient is placed in a supine position initially. After creating the pneumoperitoneum and visual entry into the abdomen, the ligament of Treitz is visualized by upward retraction of the bowel and removal of the omentum. The patient is kept in a reverse Trendelenburg position to allow the bowel to be traced. The jejunum is traced from the ligament of Treitz for 1-2 ft, and a site is chosen, which may be adhered to the abdominal wall. Four seromuscular sutures in the shape of a diamond are placed on the antimesenteric border of the jejunum. The loose ends of the sutures are used to pull the jejunum to the corresponding site over the abdominal wall. A percutaneous needle enters the jejunum, and a guidewire is passed into the jejunum. The opposite side of the abdominal wall is inspected to ensure the guidewire has not passed through. Using serial dilators, the skin, and subcutaneous tissue are dilated to make a track for the passage of the jejunostomy tube with a stent. Once the tube is in position, the stent is removed, and the balloon is inflated. The tube is secured, and laparoscopic incisions are closed with sutures and glue.[11][12]

Needle Catheter Technique

This technique is often used as part of laparotomy with major gastrointestinal resection. A submucosal tunnel is created through the anti-mesenteric well of the jejunum with a needle catheter after its introduction into the abdominal cavity. The tunnel should be about 4-5 cm. This prevents the development of a fistula after the placement of the tube. The catheter is introduced through the needle and sutured to the jejunal wall with a purse-string suture. Finally, the jejunum is attached to the peritoneal lining with sutures. Tube feeds can be started soon after surgery, within 6-12 hours.

Percutaneous Technique (Direct Percutaneous Endoscopic Jejunostomy) 

Percutaneous insertion is done with the help of endoscopy. An enteroscope or colonoscope is passed into the jejunum. Transillumination of the tip of the scope is used to identify the position of the endoscope over the abdominal wall. A trocar is inserted through the abdominal wall into the jejunum, and a guidewire is passed distally into the jejunum. The tips of an awaiting snare or forceps are used to grasp the wire. A dilator is subsequently passed to create the track for the tube, and the tube is secured similarly to a 'pull-PEG' technique.[13][14]

Complications

Tube-Related

Mechanical Complication

Tube placement for enteral feeding might cause mechanical complications. Some mechanical complications from tube feeding are listed below.

  • Tube malposition
  • Tube obstruction
  • Accidental dislodgment of tube
  • Breakage of the feeding tube
  • Leakage of the feeding tube
  • Erosion and ulceration near the site of insertion
  • Intestinal obstruction
  • Bleeding

Tube for enteral feeding can be inserted nasally through the guided percutaneous application or surgical technique.

Nasoenteral insertion is mostly done blindly by the bedside, with about 0.5% to 16% mispositioning in the pleura, trachea, or bronchial trees. This can cause the infusion of enteral feeds in the tracheobronchial tree, causing a pulmonary abscess or pneumothorax.[29] Installing air or auscultation is not an accurate method for determining proper tube placement. The best confirmation is with radiography.[30][30] The failure of bedside nasoenteral tube placement indicates fluoroscopy or endoscopy-guided tube insertion.

Infectious Complications

  • Infection at the site of tube insertion
  • Aspiration pneumonia
  • Ear and nasopharyngeal infection
  • Infective gastroenteritis with diarrhea
  • Peritonitis

Tube placement in enteral feeding is sometimes associated with the abovementioned infectious processes. Aspiration pneumonia is reported in 89% of patients on enteral feeding with no clear benefit of gastroenteric feeding over nasogastric. Distal duodenal or jejunal feeding might prevent the regurgitation of enteral feeds.[30]

Complications from the enteral feeding tube also depend on the following:

  1. The size of the tube
  2. The tube material
  3. The diameter of the tube

Spark et al. critically reviewed pulmonary complications from gastroenteric tube placement. In 9931 cases of tube placement, there was 1.9% (187) malposition in the tracheobronchial tree. The 187 misplaced tubes resulted in 35 pneumothoraxes (18.7%) with at least 5 mortalities.[31]

Gastrointestinal Complications

Enteral feeding is associated with several GI complications

  • Nausea and vomiting
  • Diarrhea
  • Constipation
  • Cramps and bloating
  • Regurgitation and aspiration 

Nausea

Nausea and vomiting are common after the initiation of enteral feeding, about 20% to 30%. Non-occlusive bowel necrosis and aspiration can also occur. This is associated with high mortality.[32][33]

Diarrhea

This is the most gastrointestinal complication seen in enteral feeding. Diarrhea occurs in about 30% of patients admitted to the medical or surgical wards and about 80% of patients in the ICU.[28][34][35]

Diarrhea in enteral feeding is a result of many factors. Using antibiotics and other medications in enteral feeding is a common cause of diarrhea—medications like antacids, oral magnesium or phosphate, antacids, and prokinetic agents. Oral and intravenous antibiotics can also favor the growth of Clostridium difficile, Escherichia coli, and Klebsiella. The sorbitol-containing solution can also trigger profuse diarrhea in patients on enteral feeding. Using fiber based on the meta-analysis result can significantly reduce the incidence of enteral feeding-associated diarrhea, especially in high-risk, post-surgically, and critically ill patients.

Constipation

This is a less common complication associated with enteral feeding. Constipation is more common in patients on long-term enteral feeds. Some studies suggest that fiber supplementation might help reduce the percentage of patients reporting constipation in enteral feeding.

Aspiration Pneumonia

This is a potentially life-threatening complication from enteral feeding. It occurs because of the aspiration of oral secretion or gastric secretions with enteric secretions. Aspiration is more common when patients are fed via a nasogastric tube in a supine position.[36][37] The cause of aspiration pneumonia in enteral feeding is multifactorial.

  • Gravitational backflow
  • Lower esophageal sphincter impairment
  • Infrequent contract of the esophagus
  • The presence of a tube near the gastric cardia
  • Impaired level of consciousness
  • Poor gag and cough reflexes are seen in neurologically impaired patients with stroke or dementia [38]

To prevent aspiration, place the enteral feeding tube about 40 cm distal to the ligament of Treitz. This applies to patients with a higher risk of aspiration.[39][40]

Metabolic Complications

Enteral feeding is associated with metabolic complications. A common complication seen in malnourished patients is refeeding syndrome. This phenomenon was first described in Far East prisoners during the Second World War.[41][42][43]

Patients with anorexia nervosa, hyperemesis, alcoholism, and malabsorption syndrome like short bowel syndrome who are started on enteral feeding are prone to refeeding syndrome.

The pathophysiology of the refeeding syndrome is still poorly understood. In starvation, the cellular membrane system downregulates with the loss of intracellular potassium, phosphorus, magnesium, and calcium. The total body content of these ions is depleted. The cell's intake of sodium and water is also increased. The sudden reversal of malnutrition with enteral feeding is due to the cell's uptake of potassium, phosphorus, magnesium, and calcium back with the simultaneous movement of water and sodium out of the cells. The undernourished kidney is also impaired and cannot handle the sodium and water load.

Hypophosphataemia is the hallmark of refeeding syndrome. Hypophosphatemia can cause rhabdomyolysis, cardiac failure, arrhythmia, muscular weakness, leukocyte dysfunction, seizure, coma, and sudden death.[44]

The phenomenon is more common in enteral than parenteral feeding.[45]

Awareness of the syndrome is the key to treatment and prevention.

Patients at Risk for Re-feeding Syndrome

  • Chronic alcoholism
  • Anorexia nervosa
  • Postoperative patients
  • Elderly patients
  • Prolonged fasting
  • Morbid obesity associated with profound weight loss
  • Malabsorption syndrome: Cystic fibrosis, inflammatory bowel disease, and short bowel syndrome[46]

To manage refeeding syndrome, the patient's cardiovascular status should be monitored closely, preferably in the ICU. Judicious monitoring of electrolytes and micronutrients should also be implemented.

Goal caloric intake should target about 50% to 75% of daily requirements.

Body Weight

  • Less than 7 years: 80 to 100kcal/kg body weight per day
  • Seven to 10 years: 80 to 100kcal/kg body weight per day
  • Eleven to 14 years: 60 kcal/kg body weight per day
  • Fifteen to 18 years: 50kcal/kg body weight per day
  • Older than 18 years: 25 kcal/kg body weight per day, an average of 1000 kcal per day initially
  • Thiamine, riboflavin, folic acid, and pyridoxine should be supplemented, including fat-soluble vitamins A, D, E, and K.

Minerals

  • Sodium should be restricted, I mmol/kg of body weight per day or 1.5 g per day, but an adequate amount of phosphorus, magnesium, and potassium should be given.
  • Magnesium (0.8 to 1.6mmol/L)
  • For hypomagnesemia, start at 0.5 mmol/kg per day over 24 hours, then 0.25 mmol/kg of body weight per day for 5 days
  • Maintenance 0.2 mmol/kg per day intravenous or 0.5 mmol/kg per day oral
  • Hypophosphatemia
  • A normal range is 0.85 per 1.40mmol/L
  • For mild hypophosphatemia (0.6 to 0.85 mmol/L), start at 0.3 to 0.6 mmol/kg of body weight per day
  • For moderate hypophosphatemia (0.3 to 0.6 mmol/L), start at 0.3 to 0.6 mmol/kg of body weight per day
  • In less than 0.3 mmol/L of severe hypophosphatemia, give IV sodium or potassium phosphate 0.8 mmol/kg of body weight in half normal saline over 12 to 24 hours.[47][48]

Complications Associated with PEG Placement

Peristomal Wound Infection

Wound infection occurs after PEG placement with an incidence of about 3 to 70%. The technique of placement, obesity, malnutrition, steroid, or immunosuppressive therapy can cause wound site infection. Prophylactic antimicrobial therapy has been shown to reduce the incidence of wound infection after placement of PEG. First-generation cephalosporins or penicillin give adequate coverage.[49][50][51]

Clogged Feeding Tube

The clogging of feeding tubes can be as high as 25%. Clogging occurs when very thick feeds and medications are delivered through a relatively thin tube. Repeated gastric aspiration is discouraged since the low pH of gastric fluid can promote protein coagulation.[52] After delivering thick feeds or medications, the feeding tube should be flushed with about 40 to 50 mL of water. A clogged feeding tube can also be cleared mechanically using various endoscopic catheters, braided quid wires, or plastic brushes.

Peristomal Leakage

This is also a complication of PEG tube placement for enteral feeding. Several factors can contribute to leakage. Excessive pulling, tugging, and increased gastric secretion inhibit wound healing, like malnutrition, diabetes, and immunodeficiency. This can be prevented using antisecretory agents like proton pump inhibitors (PPI). Skin protectants and barrier creams can also be used.

Bleeding

The incidence of bleeding is about 2.5% after placement of PEG.[53][54] This might be secondary to mucosal tears or damage to a local vessel. Risk factor for bleeding includes the use of antiplatelet or anticoagulation therapy. Based on the current recommendations, aspirin can be continued in high-risk patients. Warfarin is recommended to be discontinued, and unfractionated heparin can be used as a bridge.[54]

Colonic Fistulae

Misplacement of PEG for enteral feeding might lead to the formation of gastrocolic, colocutaneous, and gastro colocutaneous fistulae. A gastrocolic fistula connects the wall of the stomach and the colon. Gastro colocutaneous fistula is an epithelial connection between the wall of the stomach, colon, and skin that can occur because of iatrogenic puncture or direct erosion of the PEG into the colon wall and the skin.[55][32][56][57][58]

The gastroscope should be transilluminated through the anterior abdominal wall to prevent colonic misplacement. The endoscopically visible imprint of a finger or needle is considered a “condition sine qua non” before introducing the needle through the stomach.[59] Clinically, a fistula is associated with watery diarrhea around the site of the PEG or stool around the site of insertion of the PEG. In rare instances, fistulae formation can cause peritonitis, infection, or fasciitis. Injection of contrast into the PEG can establish the diagnosis. Management can be conservative with removing PEG and awaiting the spontaneous fistulae closure. For more severe cases, endoscopic intervention or invasive laparotomy with colonic exploration might be necessary.

Pneumoperitoneum

This can occur in 8% to 18% of PEG tube placements.[60][61][62][27] This is a relatively benign condition that does not warrant any intervention.

Clinical Significance

Clinical significance cannot be overemphasized. Utilizing the gut to provide nutrients helps maintain gut integrity, stimulation, and modulation of the immunological properties of the GI tract.[63]

Enhancing Healthcare Team Outcomes

Improving the outcome of enteral feeding requires an interprofessional approach. Enteral feeding involves coordination among the nutritional support team. The nutrition support team is made up of the following:

  • Clinician
  • Nutrition nurse specialist
  • Dietician
  • Pharmacist

The clinician coordinates and directs the care related to enteral feeding. The clinician determines the optimal feeding regimen for the patient. A nutrition nurse specialist is primarily responsible for educating the patient on using the feeding tube. The nurse also supervises the tube care and notifies the clinician if any complications develop. The dietician manages the evaluation of the nutritional requirements, including the calculation of the daily caloric need and the optimal fluid requirements. The pharmacist provides the enteral feed and can mix and compound parenteral nutrition. The pharmacist advises on the compatibility of nutrients and interaction. Other ancillary staff include the social worker, physical, occupational, and speech therapists, as well as a case manager, who helps arrange home supplies.[64] Care coordination, open communication, and accurate patient record-keeping are all aspects of the interprofessional care model that drive optimal patient outcomes.

References


[1]

Seres DS, Valcarcel M, Guillaume A. Advantages of enteral nutrition over parenteral nutrition. Therapeutic advances in gastroenterology. 2013 Mar:6(2):157-67. doi: 10.1177/1756283X12467564. Epub     [PubMed PMID: 23503324]

Level 3 (low-level) evidence

[2]

Mainous MR, Block EF, Deitch EA. Nutritional support of the gut: how and why. New horizons (Baltimore, Md.). 1994 May:2(2):193-201     [PubMed PMID: 7922444]

Level 3 (low-level) evidence

[3]

Volpe A, Malakounides G. Feeding tubes in children. Current opinion in pediatrics. 2018 Oct:30(5):665-670. doi: 10.1097/MOP.0000000000000666. Epub     [PubMed PMID: 30004947]

Level 3 (low-level) evidence

[4]

Scott R,Bowling TE, Enteral tube feeding in adults. The journal of the Royal College of Physicians of Edinburgh. 2015 Mar     [PubMed PMID: 25874832]


[5]

Tuna M, Latifi R, El-Menyar A, Al Thani H. Gastrointestinal tract access for enteral nutrition in critically ill and trauma patients: indications, techniques, and complications. European journal of trauma and emergency surgery : official publication of the European Trauma Society. 2013 Jun:39(3):235-42. doi: 10.1007/s00068-013-0274-6. Epub 2013 Mar 22     [PubMed PMID: 26815229]


[6]

Holmes S. Enteral nutrition: an overview. Nursing standard (Royal College of Nursing (Great Britain) : 1987). 2012 May 30-Jun 5:26(39):41-6     [PubMed PMID: 22787992]

Level 3 (low-level) evidence

[7]

Pennington CR, Powell-Tuck J, Shaffer J. Review article: artificial nutritional support for improved patient care. Alimentary pharmacology & therapeutics. 1995 Oct:9(5):471-81     [PubMed PMID: 8580266]


[8]

Payne-James J,Silk D, Enteral nutrition: background, indications and management. Bailliere's clinical gastroenterology. 1988 Oct     [PubMed PMID: 3149904]


[9]

Frankenfield D, Smith JS, Cooney RN. Validation of 2 approaches to predicting resting metabolic rate in critically ill patients. JPEN. Journal of parenteral and enteral nutrition. 2004 Jul-Aug:28(4):259-64     [PubMed PMID: 15291408]

Level 1 (high-level) evidence

[10]

Bonet Saris A, Márquez Vácaro JA, Serón Arbeloa C, Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE). [Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): macro-and micronutrient requirements]. Medicina intensiva. 2011 Nov:35 Suppl 1():17-21. doi: 10.1016/S0210-5691(11)70004-3. Epub     [PubMed PMID: 22309747]

Level 3 (low-level) evidence

[11]

Fernández Ortega EJ, Ordóñez González FJ, Blesa Malpica AL. [Nutritional support in the critically ill patient: to whom, how, and when?]. Nutricion hospitalaria. 2005 Jun:20 Suppl 2():9-12     [PubMed PMID: 15981841]


[12]

Singer P,Berger MM,Van den Berghe G,Biolo G,Calder P,Forbes A,Griffiths R,Kreyman G,Leverve X,Pichard C,ESPEN, ESPEN Guidelines on Parenteral Nutrition: intensive care. Clinical nutrition (Edinburgh, Scotland). 2009 Aug     [PubMed PMID: 19505748]


[13]

López Martínez J, Sánchez-Izquierdo Riera JA, Jiménez Jiménez FJ, Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE). [Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): acute renal failure]. Medicina intensiva. 2011 Nov:35 Suppl 1():22-7. doi: 10.1016/S0210-5691(11)70005-5. Epub     [PubMed PMID: 22309748]

Level 3 (low-level) evidence

[14]

Fiaccadori E, Cremaschi E. Nutritional assessment and support in acute kidney injury. Current opinion in critical care. 2009 Dec:15(6):474-80. doi: 10.1097/MCC.0b013e328332f6b2. Epub     [PubMed PMID: 19812486]

Level 3 (low-level) evidence

[15]

Montejo González JC, Mesejo A, Bonet Saris A, Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE). [Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): liver failure and transplantation]. Medicina intensiva. 2011 Nov:35 Suppl 1():28-32. doi: 10.1016/S0210-5691(11)70006-7. Epub     [PubMed PMID: 22309749]

Level 3 (low-level) evidence

[16]

Grau Carmona T, López Martínez J, Vila García B, Metabolism and Nutrition Working Group of the Spanish Society of Intensive Care Medicine and Coronary units. Guidelines for specialized nutritional and metabolic support in the critically-ill patient: update. Consensus SEMICYUC-SENPE: respiratory failure. Nutricion hospitalaria. 2011 Nov:26 Suppl 2():37-40. doi: 10.1590/S0212-16112011000800008. Epub     [PubMed PMID: 22411517]

Level 1 (high-level) evidence

[17]

Blesa Malpica AL, García de Lorenzo y Mateos A, Robles González A, Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE). [Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): patient with polytrauma]. Medicina intensiva. 2011 Nov:35 Suppl 1():68-71. doi: 10.1016/S0210-5691(11)70014-6. Epub     [PubMed PMID: 22309757]

Level 3 (low-level) evidence

[18]

Wernerman J. Glutamine and acute illness. Current opinion in critical care. 2003 Aug:9(4):279-85     [PubMed PMID: 12883282]

Level 3 (low-level) evidence

[19]

Marik PE, Zaloga GP. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive care medicine. 2008 Nov:34(11):1980-90. doi: 10.1007/s00134-008-1213-6. Epub 2008 Jul 15     [PubMed PMID: 18626628]

Level 1 (high-level) evidence

[20]

Sánchez Álvarez C, Zabarte Martínez de Aguirre M, Bordejé Laguna L, Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE). [Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): gastrointestinal surgery]. Medicina intensiva. 2011 Nov:35 Suppl 1():42-7. doi: 10.1016/S0210-5691(11)70009-2. Epub     [PubMed PMID: 22309752]

Level 3 (low-level) evidence

[21]

Bordejé Laguna L, Lorencio Cárdenas C, Acosta Escribano J, Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE). [Guidelines for specialized nutritional and metabolic support in the critically ill-patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): severe acute pancreatitis]. Medicina intensiva. 2011 Nov:35 Suppl 1():33-7. doi: 10.1016/S0210-5691(11)70007-9. Epub     [PubMed PMID: 22309750]

Level 3 (low-level) evidence

[22]

Gopalan S,Khanna S, Enteral nutrition delivery technique. Current opinion in clinical nutrition and metabolic care. 2003 May     [PubMed PMID: 12690265]

Level 3 (low-level) evidence

[23]

Marks JM, Ponsky JL. Access routes for enteral nutrition. The Gastroenterologist. 1995 Jun:3(2):130-40     [PubMed PMID: 7640944]


[24]

Engelke M, Grund KE, Schilling D, Beilenhoff U, Kern-Waechter E, Engelke O, Stebner F, Kugler C. [Comparison of safety insertion techniques of percutaneous endoscopic gastrostomy in nurses and physicians - a non-randomized interventional pilot study on a simulation model]. Zeitschrift fur Gastroenterologie. 2018 Mar:56(3):239-248. doi: 10.1055/s-0043-120350. Epub 2017 Nov 7     [PubMed PMID: 29113003]

Level 2 (mid-level) evidence

[25]

DiSario JA. Endoscopic approaches to enteral nutritional support. Best practice & research. Clinical gastroenterology. 2006:20(3):605-30     [PubMed PMID: 16782532]


[26]

Byrne KR,Fang JC, Endoscopic placement of enteral feeding catheters. Current opinion in gastroenterology. 2006 Sep     [PubMed PMID: 16891888]

Level 3 (low-level) evidence

[27]

Bischoff SC, Kester L, Meier R, Radziwill R, Schwab D, Thul P, Working group for developing the guidelines for parenteral nutrition of The German Association for Nutritional Medicine. Organisation, regulations, preparation and logistics of parenteral nutrition in hospitals and homes; the role of the nutrition support team - Guidelines on Parenteral Nutrition, Chapter 8. German medical science : GMS e-journal. 2009 Nov 18:7():Doc20. doi: 10.3205/000079. Epub 2009 Nov 18     [PubMed PMID: 20049081]


[28]

Majid HA, Emery PW, Whelan K. Definitions, attitudes, and management practices in relation to diarrhea during enteral nutrition: a survey of patients, nurses, and dietitians. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 2012 Apr:27(2):252-60. doi: 10.1177/0884533611431986. Epub 2012 Jan 5     [PubMed PMID: 22223668]

Level 2 (mid-level) evidence

[29]

Halloran O, Grecu B, Sinha A. Methods and complications of nasoenteral intubation. JPEN. Journal of parenteral and enteral nutrition. 2011 Jan:35(1):61-6. doi: 10.1177/0148607110370976. Epub 2010 Oct 26     [PubMed PMID: 20978245]


[30]

Levy H, Nasogastric and nasoenteric feeding tubes. Gastrointestinal endoscopy clinics of North America. 1998 Jul     [PubMed PMID: 9654567]


[31]

Sparks DA, Chase DM, Coughlin LM, Perry E. Pulmonary complications of 9931 narrow-bore nasoenteric tubes during blind placement: a critical review. JPEN. Journal of parenteral and enteral nutrition. 2011 Sep:35(5):625-9. doi: 10.1177/0148607111413898. Epub 2011 Jul 28     [PubMed PMID: 21799186]


[32]

Hull MA, Rawlings J, Murray FE, Field J, McIntyre AS, Mahida YR, Hawkey CJ, Allison SP. Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy. Lancet (London, England). 1993 Apr 3:341(8849):869-72     [PubMed PMID: 8096573]


[33]

Marvin RG, McKinley BA, McQuiggan M, Cocanour CS, Moore FA. Nonocclusive bowel necrosis occurring in critically ill trauma patients receiving enteral nutrition manifests no reliable clinical signs for early detection. American journal of surgery. 2000 Jan:179(1):7-12     [PubMed PMID: 10737569]


[34]

Jack L,Coyer F,Courtney M,Venkatesh B, Diarrhoea risk factors in enterally tube fed critically ill patients: a retrospective audit. Intensive     [PubMed PMID: 21087731]

Level 2 (mid-level) evidence

[35]

Ritz MA, Fraser R, Tam W, Dent J. Impacts and patterns of disturbed gastrointestinal function in critically ill patients. The American journal of gastroenterology. 2000 Nov:95(11):3044-52     [PubMed PMID: 11095317]


[36]

NAGLER R, SPIRO HM. PERSISTENT GASTROESOPHAGEAL REFLUX INDUCED DURING PROLONGED GASTRIC INTUBATION. The New England journal of medicine. 1963 Sep 5:269():495-500     [PubMed PMID: 14043246]


[37]

Gomes GF, Pisani JC, Macedo ED, Campos AC. The nasogastric feeding tube as a risk factor for aspiration and aspiration pneumonia. Current opinion in clinical nutrition and metabolic care. 2003 May:6(3):327-33     [PubMed PMID: 12690267]

Level 3 (low-level) evidence

[38]

Ukleja A, Altered GI motility in critically Ill patients: current understanding of pathophysiology, clinical impact, and diagnostic approach. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 2010 Feb     [PubMed PMID: 20130154]

Level 3 (low-level) evidence

[39]

Silk DB. The evolving role of post-ligament of Trietz nasojejunal feeding in enteral nutrition and the need for improved feeding tube design and placement methods. JPEN. Journal of parenteral and enteral nutrition. 2011 May:35(3):303-7. doi: 10.1177/0148607110387799. Epub 2011 Mar 10     [PubMed PMID: 21393640]


[40]

White H, Sosnowski K, Tran K, Reeves A, Jones M. A randomised controlled comparison of early post-pyloric versus early gastric feeding to meet nutritional targets in ventilated intensive care patients. Critical care (London, England). 2009:13(6):R187. doi: 10.1186/cc8181. Epub 2009 Nov 25     [PubMed PMID: 19930728]

Level 1 (high-level) evidence

[41]

SCHNITKER MA, MATTMAN PE, BLISS TL. A clinical study of malnutrition in Japanese prisoners of war. Annals of internal medicine. 1951 Jul:35(1):69-96     [PubMed PMID: 14847450]


[42]

KEYS A, The residues of malnutrition and starvation. Science (New York, N.Y.). 1950 Sep 29     [PubMed PMID: 14781769]


[43]

Marinella MA. The refeeding syndrome and hypophosphatemia. Nutrition reviews. 2003 Sep:61(9):320-3     [PubMed PMID: 14552069]

Level 3 (low-level) evidence

[44]

Terlevich A, Hearing SD, Woltersdorf WW, Smyth C, Reid D, McCullagh E, Day A, Probert CS. Refeeding syndrome: effective and safe treatment with Phosphates Polyfusor. Alimentary pharmacology & therapeutics. 2003 May 15:17(10):1325-9     [PubMed PMID: 12755846]


[45]

Zeki S, Culkin A, Gabe SM, Nightingale JM. Refeeding hypophosphataemia is more common in enteral than parenteral feeding in adult in patients. Clinical nutrition (Edinburgh, Scotland). 2011 Jun:30(3):365-8. doi: 10.1016/j.clnu.2010.12.001. Epub 2011 Jan 21     [PubMed PMID: 21256638]

Level 2 (mid-level) evidence

[46]

Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what it is, and how to prevent and treat it. BMJ (Clinical research ed.). 2008 Jun 28:336(7659):1495-8. doi: 10.1136/bmj.a301. Epub     [PubMed PMID: 18583681]


[47]

Marinella MA. Refeeding syndrome in cancer patients. International journal of clinical practice. 2008 Mar:62(3):460-5. doi: 10.1111/j.1742-1241.2007.01674.x. Epub 2008 Jan 19     [PubMed PMID: 18218007]

Level 3 (low-level) evidence

[48]

Crook MA, Hally V, Panteli JV. The importance of the refeeding syndrome. Nutrition (Burbank, Los Angeles County, Calif.). 2001 Jul-Aug:17(7-8):632-7     [PubMed PMID: 11448586]


[49]

Safadi BY, Marks JM, Ponsky JL. Percutaneous endoscopic gastrostomy. Gastrointestinal endoscopy clinics of North America. 1998 Jul:8(3):551-68     [PubMed PMID: 9654568]


[50]

Lipp A,Lusardi G, Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy. The Cochrane database of systematic reviews. 2006 Oct 18     [PubMed PMID: 17054265]

Level 1 (high-level) evidence

[51]

Jafri NS, Mahid SS, Minor KS, Idstein SR, Hornung CA, Galandiuk S. Meta-analysis: antibiotic prophylaxis to prevent peristomal infection following percutaneous endoscopic gastrostomy. Alimentary pharmacology & therapeutics. 2007 Mar 15:25(6):647-56     [PubMed PMID: 17311597]

Level 1 (high-level) evidence

[52]

Powell KS, Marcuard SP, Farrior ES, Gallagher ML. Aspirating gastric residuals causes occlusion of small-bore feeding tubes. JPEN. Journal of parenteral and enteral nutrition. 1993 May-Jun:17(3):243-6     [PubMed PMID: 8505829]


[53]

Amann W, Mischinger HJ, Berger A, Rosanelli G, Schweiger W, Werkgartner G, Fruhwirth J, Hauser H. Percutaneous endoscopic gastrostomy (PEG). 8 years of clinical experience in 232 patients. Surgical endoscopy. 1997 Jul:11(7):741-4     [PubMed PMID: 9214323]


[54]

Anderson MA,Ben-Menachem T,Gan SI,Appalaneni V,Banerjee S,Cash BD,Fisher L,Harrison ME,Fanelli RD,Fukami N,Ikenberry SO,Jain R,Khan K,Krinsky ML,Lichtenstein DR,Maple JT,Shen B,Strohmeyer L,Baron T,Dominitz JA, Management of antithrombotic agents for endoscopic procedures. Gastrointestinal endoscopy. 2009 Dec     [PubMed PMID: 19889407]


[55]

Larson DE, Burton DD, Schroeder KW, DiMagno EP. Percutaneous endoscopic gastrostomy. Indications, success, complications, and mortality in 314 consecutive patients. Gastroenterology. 1987 Jul:93(1):48-52     [PubMed PMID: 3108063]

Level 2 (mid-level) evidence

[56]

Berger SA, Zarling EJ. Colocutaneous fistula following migration of PEG tube. Gastrointestinal endoscopy. 1991 Jan-Feb:37(1):86-8     [PubMed PMID: 1900799]

Level 3 (low-level) evidence

[57]

Guloglu R, Taviloglu K, Alimoglu O. Colon injury following percutaneous endoscopic gastrostomy tube insertion. Journal of laparoendoscopic & advanced surgical techniques. Part A. 2003 Feb:13(1):69-72     [PubMed PMID: 12676027]

Level 3 (low-level) evidence

[58]

Friedmann R,Feldman H,Sonnenblick M, Misplacement of percutaneously inserted gastrostomy tube into the colon: report of 6 cases and review of the literature. JPEN. Journal of parenteral and enteral nutrition. 2007 Nov-Dec     [PubMed PMID: 17947601]

Level 3 (low-level) evidence

[59]

Ponsky JL, Gauderer MW. Percutaneous endoscopic gastrostomy: indications, limitations, techniques, and results. World journal of surgery. 1989 Mar-Apr:13(2):165-70     [PubMed PMID: 2499128]


[60]

Wiesen AJ, Sideridis K, Fernandes A, Hines J, Indaram A, Weinstein L, Davidoff S, Bank S. True incidence and clinical significance of pneumoperitoneum after PEG placement: a prospective study. Gastrointestinal endoscopy. 2006 Dec:64(6):886-9     [PubMed PMID: 17140892]


[61]

Nazarian A, Cross W, Kowdley GC. Pneumoperitoneum after percutaneous endoscopic gastrostomy among adults in the intensive care unit: incidence, predictive factors, and clinical significance. The American surgeon. 2012 May:78(5):591-4     [PubMed PMID: 22546133]

Level 2 (mid-level) evidence

[62]

Blum CA,Selander C,Ruddy JM,Leon S, The incidence and clinical significance of pneumoperitoneum after percutaneous endoscopic gastrostomy: a review of 722 cases. The American surgeon. 2009 Jan     [PubMed PMID: 19213395]

Level 2 (mid-level) evidence

[63]

Kudsk KA. Beneficial effect of enteral feeding. Gastrointestinal endoscopy clinics of North America. 2007 Oct:17(4):647-62     [PubMed PMID: 17967372]


[64]

Nightingale J. Nutrition support teams: how they work, are set up and maintained. Frontline gastroenterology. 2010 Oct:1(3):171-177. doi: 10.1136/fg.2009.000224. Epub 2010 Aug 5     [PubMed PMID: 28839571]